PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Look Who’s On the Move!

      Look Who’s On the Move!

      Life Sciences BC Board of Directors Announcement

      VANCOUVER, British Columbia--(BUSINESS WIRE)--Following a well-attended AGM, Life Sciences BC is pleased to announce new Board of Directors members, with thanks to those who...
      Admin -
      Look Who’s On the Move!

      Sonoma Biotherapeutics Expands Leadership Team with the Appointment of Doug Sheehy, J.D., as Chief Legal Officer and Secretary

      SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, an immune tolerance company focused on the development of regulatory T cell (Treg) therapies, today announced...
      Admin -
      Look Who’s On the Move!

      Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development

      FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease...
      Admin -
      Look Who’s On the Move!

      Aerie Pharmaceuticals Announces Appointment of Carolyn McAuliffe, Senior Director, Communications

      DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of...
      Admin -
      Look Who’s On the Move!

      Resolve Biosciences Appoints Erik Wiberg as Chief Financial Officer

      MONHEIM AM RHEIN, Germany--(BUSINESS WIRE)--Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Erik Wiberg as Chief Financial Officer. In this...
      Admin -
      Look Who’s On the Move!

      Xenter, Inc. Appoints Mark Turco, MD as President of Xenter’s Medical Technologies Business Unit

      SALT LAKE CITY--(BUSINESS WIRE)--Following the formation of the Xenter Therapeutics business unit, Xenter, Inc. (XenterMD.com), the first purpose-built medical device-data-drug technologies company, today announced...
      Admin -
      123...316Page 1 of 316

      Recent Articles

      Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19

      Regulatory Affairs

      Life Sciences BC Board of Directors Announcement

      Look Who’s On the Move!

      Janssen Receives Positive CHMP Opinion for BYANNLI® (6-monthly Paliperidone Palmitate) for the Maintenance Treatment of Schizophrenia in Adults

      Industry News

      Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal...

      Industry News

      Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy for Certain Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative Breast...

      Industry News

      Appili Therapeutics Announces Completion of Patient Enrollment for Avigan®/Reeqonus™ Viral Shedding Sub- Study for Mild-to-Moderate COVID-19 Patients

      Industry News

      IMFINZI Combined With Novel Immunotherapies Improved Clinical Outcomes for Patients With Unresectable, Stage III Non-Small Cell Lung Cancer

      Industry News

      Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to Humira®

      Industry News

      ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically meaningful and durable response in patients with HER2-positive advanced gastric cancer in DESTINY-Gastric02 Phase II trial

      Industry News

      ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial

      Industry News

      BeiGene Receives Positive CHMP Opinion for BRUKINSA® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia

      Industry News

      Deciphera Announces Positive CHMP Opinion for QINLOCK® for the Treatment of Fourth-line Gastrointestinal Stromal Tumor

      Industry News

      AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines

      Industry News

      Moderna Highlights New Clinical Data on its COVID-19 Vaccine

      Industry News

      Takeda’s EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC

      Regulatory Affairs

      2021 © Copyright - TPMG